[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100530987":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":10,"centralContacts":30,"locations":36,"responsibleParty":170,"collaborators":10,"id":172,"slug":10,"hasResults":173,"nctId":174,"briefTitle":175,"officialTitle":175,"acronym":176,"eligibilityCriteria":177,"healthyVolunteers":173,"sex":178,"minAge":10,"maxAge":10,"enrollmentInfo":179,"targetDuration":182,"studyType":183,"phases":10,"briefSummary":184,"conditions":185,"keywords":188,"overallStatus":39,"whyStopped":10,"lastUpdateSubmitDate":192,"lastUpdatePostDateStruct":193,"startDateStruct":196,"completionDateStruct":198,"leadSponsor":200,"locationsCount":201},{"fullName":5,"class":6},"Mirum Pharmaceuticals, Inc.","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Alagille syndrome (ALGS)",null,"* A clinically and\u002For genetically confirmed ALGS diagnosis\n* Participant prescribed Livmarli",[13],"Drug: Livmarli",{"label":15,"type":10,"description":16,"interventionNames":17},"Progressive familial intrahepatic cholestasis (PFIC)","* A clinically and\u002For genetically confirmed PFIC diagnosis\n* Prescribed Livmarli",[13],[19,26],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"DRUG","Livmarli","The recommended dosage is 380 mcg\u002Fkg once daily.",[9],[25],"Maralixibat",{"type":20,"name":21,"description":27,"armGroupLabels":28,"otherNames":29},"The recommended dosage us 570 mcg\u002Fkg twice daily.",[15],[25],[31],{"name":32,"role":33,"phone":34,"phoneExt":10,"email":35},"Clinical Trials Mirum","CONTACT","+16506674085","Clinical Trials \u003Cclinicaltrials@mirumpharma.com>;",[37,59,74,91,106,121,138,155],{"facility":38,"status":39,"city":40,"state":41,"zip":42,"country":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"Children's Hospital Los Angeles CHLA","RECRUITING","Los Angeles","California","90027","United States",{"type":45,"coordinates":46},"Point",[47,48],-118.24368,34.05223,{"lat":48,"lon":47},[51,54,56],{"name":52,"role":33,"phone":10,"phoneExt":10,"email":53},"Chuan-Hao Lin, MD","ChLin@chla.usc.edu",{"name":55,"role":33,"phone":10,"phoneExt":10,"email":10},"George Yanni",{"name":57,"role":58,"phone":10,"phoneExt":10,"email":10},"Chuan-Hao Lin","PRINCIPAL_INVESTIGATOR",{"facility":60,"status":39,"city":61,"state":62,"zip":63,"country":43,"cosmosGeoPoint":64,"geoPoint":68,"contacts":69},"Section of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics and the Digestive Health Institute, Children's Hospital of Colorado and University of Colorado","Aurora","Colorado","80045",{"type":45,"coordinates":65},[66,67],-104.83192,39.72943,{"lat":67,"lon":66},[70,73],{"name":71,"role":33,"phone":10,"phoneExt":10,"email":72},"Shikha S. Sundaram","Shikha.Sundaram@childrenscolorado.org",{"name":71,"role":58,"phone":10,"phoneExt":10,"email":10},{"facility":75,"status":39,"city":76,"state":77,"zip":78,"country":43,"cosmosGeoPoint":79,"geoPoint":83,"contacts":84},"Children's Healthcare of Atlanta - Emory University School of Medicine","Atlanta","Georgia","30322",{"type":45,"coordinates":80},[81,82],-84.38798,33.749,{"lat":82,"lon":81},[85,89],{"name":86,"role":33,"phone":87,"phoneExt":10,"email":88},"Angela Stallworth","404-785-3279","Angela.Stallworth@choa.org",{"name":90,"role":58,"phone":10,"phoneExt":10,"email":10},"Chrissy Lopez",{"facility":92,"status":39,"city":93,"state":94,"zip":95,"country":43,"cosmosGeoPoint":96,"geoPoint":100,"contacts":101},"Children's Mercy Kansas City, Department of Gastroenterology, Section of Hepatology","Kansas City","Missouri","64108",{"type":45,"coordinates":97},[98,99],-94.57857,39.09973,{"lat":99,"lon":98},[102,105],{"name":103,"role":33,"phone":10,"phoneExt":10,"email":104},"Ryan T. Fischer","rtfischer@cmh.edu",{"name":103,"role":58,"phone":10,"phoneExt":10,"email":10},{"facility":107,"status":39,"city":108,"state":109,"zip":110,"country":43,"cosmosGeoPoint":111,"geoPoint":115,"contacts":116},"Oregon Health and Science University, Division of Pediatric Gastroenterology, Department of Pediatrics","Portland","Oregon","97239",{"type":45,"coordinates":112},[113,114],-122.67621,45.52345,{"lat":114,"lon":113},[117,120],{"name":118,"role":33,"phone":10,"phoneExt":10,"email":119},"Henry C. Lin","linhe@ohsu.edu",{"name":118,"role":58,"phone":10,"phoneExt":10,"email":10},{"facility":122,"status":39,"city":123,"state":124,"zip":125,"country":43,"cosmosGeoPoint":126,"geoPoint":130,"contacts":131},"Children's Hospital of Philadelphia","Philadelphia","Pennsylvania","19104",{"type":45,"coordinates":127},[128,129],-75.16362,39.95238,{"lat":129,"lon":128},[132,136],{"name":133,"role":33,"phone":134,"phoneExt":10,"email":135},"Kathleen Loomes","267-426-7223","LOOMES@email.chop.edu",{"name":137,"role":58,"phone":10,"phoneExt":10,"email":10},"Kathleen Loomes, MD",{"facility":139,"status":39,"city":140,"state":124,"zip":141,"country":43,"cosmosGeoPoint":142,"geoPoint":146,"contacts":147},"Children Hospital of Pittsburgh","Pittsburgh","15260",{"type":45,"coordinates":143},[144,145],-79.99589,40.44062,{"lat":145,"lon":144},[148,151,153],{"name":149,"role":33,"phone":10,"phoneExt":10,"email":150},"Simon Horslen, MD","horslensp@upmc.edu",{"name":152,"role":33,"phone":10,"phoneExt":10,"email":10},"James E. Squires",{"name":154,"role":58,"phone":10,"phoneExt":10,"email":10},"Simon Horslen",{"facility":156,"status":39,"city":157,"state":158,"zip":159,"country":43,"cosmosGeoPoint":160,"geoPoint":164,"contacts":165},"University of Utah, Division of Pediatric Gastroenterology, Hepatology and Nutrition","Salt Lake City","Utah","84112",{"type":45,"coordinates":161},[162,163],-111.89105,40.76078,{"lat":163,"lon":162},[166,169],{"name":167,"role":33,"phone":10,"phoneExt":10,"email":168},"M. Kyle Jensen","kyle.jensen@hsc.utah.edu",{"name":167,"role":58,"phone":10,"phoneExt":10,"email":10},{"type":171,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100530987",false,"NCT06193928","Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US)","LEAP","Inclusion Criteria:\n\n* A clinically and\u002For genetically confirmed ALGS diagnosis or PFIC diagnosis\n* Participant prescribed Livmarli\n\nExclusion Criteria:\n\n* Refusal to provide informed consent\u002Fassent (if required by the local IRB)\n* Previously or currently on Livmarli through participation in a clinical study or expanded access program\n* Participants who have previously received an SBD or LT\n* Any condition or abnormalities that, in the opinion of the investigator, may interfere with the participant participating in or completing the study\n* Participants who have received an investigational drug within 30 days of the first dose of Livmarli","ALL",{"count":180,"type":181},70,"ESTIMATED","5 Years","OBSERVATIONAL","The objective of this 5-year, prospective, observational cohort study is to evaluate the long-term safety and clinical outcomes of patients with Alagille syndrome (ALGS) or Progressive familial intrahepatic cholestasis (PFIC) treated with Livmarli.",[186,187],"Alagille Syndrome","Progressive Familial Intrahepatic Cholestasis",[189,190,191,21,186,187],"ALGS","Liver Diseases","PFIC","2025-05-21",{"date":194,"type":195},"2025-05-25","ACTUAL",{"date":197,"type":195},"2023-09-21",{"date":199,"type":181},"2030-09-20",{"name":5,"class":6},8]